Lipid role in the immune system November/December 2021
By Rebecca Guenard
In This Section
- The new bio-based surfactant feedstock January 2022
- Lipid role in the immune system November/December 2021
- New essential dietary lipids? October 2021
- Gut Instincts September 2021
- Can computers make better plant-based foods? July/August 2021
- Poisson from a petri dish June 2021
- The latest additions to eco-friendly cleaning May 2021
- Preserving emulsions with plant-based antioxidants April 2021
- Developments in green surfactants for enhanced oil recovery March 2021
- Alternative base oils: a perspective March 2021
- The COVID-19 pandemic, one year later March 2021
- The green machine: commercializing microalgae products February 2021
- Bio-based (edible) oils: feedstock for lubricants of the future January 2021
- The latest on liposomes January 2021
- Fatty acids and athletic performance November/December 2020
- Where are lubricants headed November/December 2020
- New developments in vegetable oil materials science October 2020
- Agriculture at risk: preparing the oilseed industry for a warmer world September 2020
- Science highlights from a cancelled 2020 AM&E July/August 2020
- Managing your career in times of change June 2020
- Lipidomics comes of age May 2020
- Minimally processed oils April 2020
- The high-throughput frontier March 2020
- Nurturing innovation: how AOCS industries are fostering progress February 2020
- The trouble with studying omega-3s and the brain January 2020
- Understanding pulse anti-nutrients January 2020
- Digitizing manufacturing: how companies are using data to improve production November/December 2019
- Weaving together genetics, epigenetics, and the microbiome to optimize human nutrition October 2019
- Taking the cream out of ice cream September 2019
- Science highlights from St. Louis July/August 2019
- Biotechnology conquers consumer goods June 2019
- Cool characterization methods and where to find them May 2019
- Fermentation, the new protein supply chain April 2019
- Oleogels for drug delivery March 2019
- The complexity of clean-label cosmetics February 2019
- Rethinking plastic packaging January 2019
- Trends in synthetic and natural antioxidants for shelf life extension of meat and meat products November/December 2018
- The icing on the cake October 2018
- Enhancing oxidative stability and shelf life of frying oils with antioxidants September 2018
- Under arrest: investigating factors that govern partial coalescence July/August 2018
- Unconventional Oils June 2018
- Beauty from within May 2018
- Pulses rising April 2018
- Lessons learned from Hurricane Harvey March 2018
- Clean meat February 2018
- What makes your shortening suitable for fancy croissants, puff and Danish pastry? January 2018
- Strategic role of peanuts in sustainable global food security November/December 2017
- Science beyond borders: international student exchange October 2017
- Clean label: the next generation September 2017
- Science snapshots from Orlando July/August 2017
- Five new AOCS methods June 2017
- The whys and wherefores of life-cycle assessment May 2017
- China’s evolving edible oils industry April 2017
- The mysterious case of the arsenolipids March 2017
- Red palm oil February 2017
- The Highs and Lows of Cannabis Testing October 2016
- Chia: Superfood or superfad? January 2017
- Generational training divide November/December 2016
- Storage stability of roasted nuts and stabilization strategy using natural antioxidants September 2016
- Good vibrations: online and at-line monitoring of edible oils with vibrational spectroscopy July/August 2016
- Benchtop NMR spectroscopy for meat authentication June 2016
- Coconut oil boom May 2016
- Sink or swim: fish oil supplements and human health April 2016
- Pulsed electric field: groundbreaking technology for improving olive oil extraction March 2016
- Prescribing dietary fat: therapeutic uses of ketogenic diets February 2016
- Organogels of vegetable oil with plant wax January 2016
- The power of peptides November/December 2015
- Separation anxiety: membrane cleaning in the 21st century October 2015
- Using direct solid phase extraction to analyze persistent organic pollutants in oily food samples September 2015
- Big fat controversy: changing opinions about saturated fats June 2015
- Use of spent bleaching earth for economic and environmental benefit May 2015
- An introduction to cosmetic technology April 2015
- Food texture and nutrition: the changing roles of hydrocolloids and food fibers March 2015
- Scientists rank thousands of substances according to potential exposure level March 2015
- Clean smell does not always equal clean air February 2015
- Biotechnology: Using living systems to solve problems February 2015
- Flush to fuel January 2015
- 1970s fish oil study criticized January 2015
- Developing a high-performance, low-streak degreaser November/December 2014
- Detection, monitoring, and deleterious health effects of lipid oxidation November/December 2014
- Modified protein mimics taste and texture of fat October 2014
- Development of the first efficient membrane separations of cis fatty acids October 2014
- Regulatory updates on FSMA and combustible dust September 2014
- How enzymes are transforming manufacturing September 2014
- Two advances in biodiesel technology July/August 2014
- 2014 AOCS Annual Meeting & Expo July 2014
- Peanut genome sequenced June 2014
- A customized approach to frying oil June 2014
- Omics reveals subtle changes in carbon flux that lead to increased oil biosynthesis in oil palm May 2014
- Cannabis testing: a review of the current landscape May 2014
- Industrial hemp gaining traction April 2014
- Emulsions: making oil and water mix April 2014
- Lipid co-oxidation of proteins: One size does not fit all March 2014
- FSMA marches on March 2014
- Disruptive technology? Walmart’s “green” product line may signal a big change February 2014
- Pathways to novel chemicals February 2014
- Specialty lipids in pet nutrition January 2014
- EFSA releases preliminary report on occurrence of 3-MCPD in food January 2014
- Seven new biobased surfactant technologies November/December 2013
- Do oil color scales make you see red . . . or yellow? November/December 2013
- Shortage leads to green route to olefins October 2013
- Sesamol: a natural antioxidant for frying oil September 2013
- FSMA update September 2013
- Patent rights and biotech seeds July August 2013
- The other vitamin E July 2013
- Frac fever heats up June 2013
- Fat fight: Catch-22 for Western oleochemicals? June 2013
- Health and Nutrition News April 2013
- FDA asks for fees from industry to fund FSMA June 2013
- What does it take to start a biodiesel industry? April 2013
- What’s in a Claim? Would a Food Not Labeled “Natural” Taste as Sweet? March 2013
- Regulatory overview March 2013
- The preservative wars February 2013
- Plants producing DHA February 2013
- Swift response to paper on feeding GMO corn, glyphosate January 2013
- AOCS: supporting international standards January 2013
- TSCA and the regulation of renewable chemicals July August 2013
- trans Fatty acid content of foods in China January 2013
- A novel green catalytic process for biodiesel production from Jatropha November/December 2012
- The America Invents Act: Groundbreaking US patent law changes are here November/December 2012
- “Super Phos” esters: the key to higher-performance products November/December 2012
- Advances in field-portable mass spectrometers for on-site analytics October 2012
- EFSA sets upper intake level for LC-PUFA October 2012
- Malaysia: economic transformation advances oil palm industry September 2012
- High-oleic canola oils and their food applications September 2012
- Using enzymes to prepare biobased surfactants July/August 2012
- Oilseeds: at the center of food, water, and energy security July/August 2012
- Health & Nutrition News June 2012
- Hydrocolloids get personal June 2012
- The secrets of Belgian chocolate May 2012
- Plants “remember” drought, adapt May 2012
- The power of mass spectrometry in the detection of fraud April 2012
- Oil in biomass: a step-change for bioenergy production? April 2012
- The Future of LAB March 2012
- World supplies of rapeseed and canola likely to remain tight in the 2012/13 season March 2012
- Methods for differentiating recycled cooking oil needed in China February 2012
- Supercritical fluid-based extraction/processing: then and now February 2012
- Singapore: the place to be in 2012 February 2012
- The Food Safety Modernization Act and its relevance to the oilseed industry February 2012
- Oilseeds in Australia January 2012
- Hydrogen peroxide in home-care formulations November 2011
- A new generation of renewable fuels is on the horizon November 2011
- Omega-3 fatty acids: $13 billion global market October 2011
- Soy and breast cancer October 2011
- EU approves food labeling rules September 2011
- IOM panel recommends tripling vitamin D intake: Panel’s conservative approach receives criticism September 2011
- Self-assembly of lyotropic liquid crystals: from fundamentals to applications August 2011
- Sustainability watch July 2011
- Sustainability Watch July 2011
- Are algae really feasible as fuel? June 2011
- The trouble with crystal polymorphism June 2011
- Insect oils: Nutritional and industrial applications May 2011
- Reconstructing formulas April 2011
- US eggs now lower in cholesterol April 2011
- How to control eating behavior--in mice March 2011
- Maybe we don’t know beans March 2011
- Short- and long-term price forecasting for palm and lauric oils February 2011
- New 3-MCPD (glycidol ester) method February 2011
- Regulatory issues associated with the international oils & fats trade January 2011
- Point-counterpoint on UC Davis olive oil report January 2011
- Biomass--The next revolution in surfactants? December 2010
- One person’s response to a high omega-6 diet November 2010
- Crop residues as feedstock for renewable fuels November 2010
- Universal detectors for determination of lipids in biodiesel production October 2010
- New very long chain fatty acid seed oils produced through introduction of strategic genes into Brassica carinata October 2010
- Surfactants based on monounsaturated fatty acids for enhanced oil recovery September 2010
- Questioning the virginity of olive oils September 2010
- Dietary guidelines report released August 2010
- Keeping up with detergent chemistry August 2010
- News from the Expo floor July 2010
- Degumming revisited July 2010
- First high-GLA safflower oil on market June 2010
- AOCS 2.0 debuts June 2010
- Palm fatty acid distillate biodiesel: Next-generation palm biodiesel May 2010
- Palm oil pundit speaks May 2010
- What is unrefined, extra virgin cold-pressed avocado oil? April 2010
- The ultra-low-linolenic soybean market April 2010
- Dealing with the media: A cautionary tale March 2010
- Hempseed oil in a nutshell March 2010
- Carbon management 101: A conversation with Eric Jackson February 2010
- Giants of the Past: Hermann Pardun (1908-2009) February 2010
- Q&A with Bill Christie February 2010
- Update on Jatropha January 2010
- Unique properties of carbon dioxide-expanded lipids January 2010
- The market situation and political framework in Germany for biodiesel and vegetable oil December 2009
- Industrial oil crops-when will they finally deliver on their promise ? December 2009
- Chemically enhanced oil recovery stages a comeback November 2009
- Field-portable mass spectrometers for onsite analytics: What's next? October 2009
- To make biofuels, or not to make biofuels:That is the question. September 2009
- Melamine analysis at the forefront September 2009
- Global oil yields: Have we got it seriously wrong? August 2009
- Omega-3 fatty acid profiling and dietary forensics August 2009
- Oilseeds of the future part 3 July 2009
- The rise and fall of surfactants lore July 2009
- Oilseeds of the future: Part 2 June 2009
- Codex Alimentarius Commission update June 2009
- Raw material sources for the long-chain omega-3 market:Trends and sustainability. Part 3. May 2009
- Oilseeds of the future: Part 1 May 2009
- Chloroesters in foods: An emerging issue April 2009
- Raw material sources for the long-chain omega-3 market: Trends and sustainability. Part 2. April 2009
- Synthetic HDL created March 2009
- Raw material sources for the long-chain omega-3 market:Trends and sustainability. Part 1. March 2009
- A convenient way to increase legume intake February 2009
- Vitamin E’s safety controversy January 2009
- Universal mechanism of aging uncovered? January 2009
- The essential fatty acids react with enzymes to produce a group of compounds known as specialized pro-resolving mediators, or SPMs.
- Researchers continually discover new members of the four groups of precursors that comprise the SPM family, called lipoxins, resolvins, protectins, and maresins.
- These stereospecific molecules shut down inflammation and restore the body to homeostasis, a mechanism researchers are targeting for treatment as an alternative to anti-inflammatory pathways.
As the COVID-19 pandemic has dragged on for almost two years, unproven, potentially dangerous treatments for the deadly respiratory disease have surfaced periodically. First there was hydroxychloroquine, then bleach, and, most recently, public health officials in Mississippi warned their citizens against taking ivermectin—a drug meant for parasitic, not viral infections (https://tinyurl.com/csr56pjd).
Meanwhile, about 2.8 billion people worldwide have been fully vaccinated against COVID-19, and vaccination remains the best way to avoid severe illness. Monoclonal antibody infusions were granted an emergency use authorization by the US Food and Drug Administration (FDA), but in most areas the treatment is reserved for patients with severe health risks due to short supply.
Patients could someday treat COVID with a pill. In October, the pharmaceutical company Merck filed with the FDA to approve its recently developed antiviral drug. However, for now, the average patient who tests positive for COVID-19 will likely get the physician’s recommendation that has remained consistent throughout the pandemic: Take daily nutritional supplements that support the immune system. Vitamin D, omega-3 fatty acids, and selenium are particularly important micronutrients that modulate the body’s inflammatory response to viral infections.
Viruses like SARS-CoV-2 can cause some people’s immune systems to go into overdrive. If the immune system does not stop responding to the infection, symptoms may persist indefinitely, as observed in long-term COVID patients. The organ damage and eventual death experienced by millions of COVID patients is the worst-case outcome for an unabated immune response.
Researchers have puzzled over the body’s mechanisms for resolving inflammation and returning tissue to homeostasis after an acute response. The process by which the immune system initiates inflammation had been identified, but researchers were not sure of the mechanism for reversing the process. Over the last decade, they have determined that essential fatty acids are crucial to putting the brakes on inflammation. The biochemical pathways that turn off inflammation after an infection center on omega-3 fatty acids which are synthesized into a family of compounds known as lipid mediators. Here is what we know about the importance of this family of fatty acid-derived compounds in the human body.
Responding to pathogen invasion
The activities of the human immune system are an exceedingly complex, invader specific set of processes that will not be detailed here. However, generally when a pathogen bursts through a cell membrane to usurp replicating power from the nucleus, it triggers alarms that rouse an immune response. Protein-signaling molecules, called chemokines, leak from the cell and create a chemical gradient which signals a call to action. The invaded tissue becomes inflamed as a team of attendants focused on killing the pathogen flood the infection site.
Scientists now appreciate that inflammation does not just subside once an invader is conquered. Resolving inflammation is an active process that occurs in concert with the inflammatory response. Shortly after the acute inflammatory response begins, the immune system has already initiated a plan for ensuring the process will eventually end. Injured tissues must be repaired. Microbes and cellular debris—the immune system’s carnage— must be cleared.
Myriad compounds are in play during inflammation and its resolution. Polyunsaturated fatty acids (PUFA) nestled in the phospholipids of the cell membrane serve an important role. Along with PUFA carried to the site by blood plasma, those released locally from ruptured membranes are converted into eicosanoids that assist the chemokines in directing the molecular traffic arriving at the site to help fight the infection. No sooner have the PUFA been synthesized into inflammation-inducing compounds than they undergo what is called class-switching and start the resolution process.
Molecules that participate in the resolution of inflammation are called specialized pro-resolving mediators (SPMs). They are signaling molecules, locally biosynthesized, that bind to receptors and initiate cell-specific activity. As such, SPMs represent a group of compounds exhibiting a variety of stereospecific arrangements (Fig.1).
Researchers distinguish four structurally distinct families of SPM; they are lipoxins, resolvins, protectins, and maresins. The essential fatty acid-derived compounds perform the functions of turning off the influx of neutrophils while clearing the infection site of microorganisms and debris. The cleanup allows inflammation to subside and initiates healing for injured tissue.
There is no one general mechanism that these compounds follow since they target different cell types. However, SPMs commonly operate by binding to inflammatory contributors, augmenting their function by changing their shape and thus limiting their ability to migrate to an infection site.
Pro-resolving mediator activity
The SPMs derived from the omega-6 PUFA arachidonic acid (AA) were the first identified by scientists and are now the most highly studied. Although several pathways are now known, the following examples should provide some understanding for the different ways SPMs work (Table 1).
In response to infection, AA is metabolized by enzymes to form eicosanoids. The two primary eicosanoids, prostaglandins and cysteinyl leukotrienes, regulate blood flow and vascular permeability to help immune cells access a pathogen easier. Shortly after producing these pro-inflammatory compounds, the lipid mediator switches to forming resolving molecules. In the resolution phase of the immune response, instead of leukotrienes AA reacts to form lipoxins. Protein receptors expressed in an array of tissues throughout the body bind with the SPM to stimulate resolution. Lipoxins are formed through multiple enzymatic pathways that can also be triggered by the presence of aspirin or statins.
Since the discovery of lipoxins, other omega-3 fatty acid-derived compounds have been identified. Researchers have uncovered pro-resolving mediators that are synthesized from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and n-3 docosapentaenoic acid (DPA).
EPA is converted into a group of mediators referred to as E-series resolvins. The compounds serve a myriad of functions from controlling acute and chronic inflammation to helping abate neurological disorders and cancer, as well as stimulating tissue repair. In studies on inflammatory diseases, resolvins controlled vascular inflammation by modifying oxidized LDL uptake. Experiments using animal models of Alzheimer’s disease indicate that resolvins reduce neuroinflammation. They have also been observed sweeping debris from tumor cells treated with chemotherapy, thus preventing the stimulation of new tumor cell growth. E-series resolvins are reliably beneficial compounds that many researchers are eyeing as a new therapeutic target.
The D-series resolvins form from DHA and represent an even broader set of compounds. Like the E-series, they protect and repair human tissue. DHA can also be metabolized into maresins and protectins. Mucosa in the respiratory tract, for example, house DHA that can react with enzymes to form a compound, called protectin D1, which clears inflammatory fluids from infected airways.
When resolution fails
Being infected with COVID-19 opens the possibility of a persistent inflammatory response that causes tissue fibrosis, necrosis, and irreversible damage, making proper organ function impossible. A recent study showed that the blood plasma of patients with severe COVID-19 contained lower levels of lipid mediators than patients with a mild form of the virus (https://doi.org/10.1161/CIRCRESAHA.121.319142). Infectious disease specialists are familiar with this outcome since pathogens commonly target SPM biosynthesis.
Resolution mediators have been widely studied in influenza infections, since different strains elicit a variety of host immune responses. Researchers found that the more aggressive the influenza strain, the more it suppressed lipoxin formation and protectin D1 production in cells. Protectin D1 interferes directly with the influenza virus’ RNA, limiting its replication. Strategic, deadly influenza strains, like H5N1, debilitate this cellular defense upon invasion, leading to a cytokine storm that can be fatal for the host.
However, a foreign body is not always necessary for an overactive immune system to impose harm. The most prevalent human pathologies—cancer, arthritis, metabolic syndrome, chronic pain, periodontal, cardiovascular, and neurological diseases—are all rooted in chronic inflammation stemming from defective resolution. Now that this connection is widely accepted by researchers, more studies are focused on finding the cause in order to find solutions.
Impaired resolution may result from insufficient dietary intake of fatty acids or by genetic polymorphisms affecting SPM biosynthesis, as well as abnormal signaling upon receptor activation. Aging is also associated with increased inflammation leading to less physiological robustness overtime. Mice studies show that a decline in SPM levels contributes to delayed resolution response with age.
One interesting polymorphism study compared cardiovascular events by race and gender while documenting SPM levels. Coronary heart disease arises at similar rates in both Black and White patients, but cardiovascular events (such as myocardial infarction, rehospitalization, and mortality) are disproportionately higher in Black patients. The researchers found that an important E-series resolvin is significantly lower in Black individuals compared with White. In addition, protectin D1 is lower in White males compared with White females and Black patients. The particular factors associated with these correlations were not determined, but the results highlight a need for more research.
The roles of SPMs have been studied in a range of infections, including bacterial, viral, and parasitic. Resolving, as opposed to suppressing, an inflammatory response is now a burgeoning field in modern medicine. With continued research, clinicians may soon have treatment options beyond steroids and cytokine blocking drugs to tamp down hyperinflammation.
Improving the resolution response
Last year, a panel of doctors from Switzerland published a set of dietary recommendations to optimize immune system health and help Swiss people have a successful recovery should they catch COVID-19. Not surprisingly, the physicians recommended increased consumption of food containing EPA and DHA.
Both human and animal experiments indicate that increasing essential fatty acids helps the body initiate resolution and heal from inflammation. These encouraging results have led many scientists to consider targeting SPMs in a pharmacological treatment.
Synthetic lipoxins and resolvins introduced into mice, successfully reduced inflammation. Researchers observed a similar effect by indirectly stimulating lipoxin synthesis. Studies on young adults taking omega-3 supplements were given an intravenous lipopolysaccharide challenge (a common method for initiating an inflammatory response). Analysis of the participants’ blood plasma revealed that after a certain period of time SPM concentration in their plasma increased to resolve the inflammation.
Recently, scientist have homed in on a unique source for SPM production: the vagus nerve. The longest of the cranial nerves, the vagus nerve runs from the brainstem, down the neck, then branches in different directions towards visceral organs. The nerve transmits motor and sensory signals from the brain to every part of the body.
A number of scientific studies are currently focused on understanding less intuitive tasks that the vagus nerve performs, for example, acting as a line of communication between the gut and the brain. A nascent area of medicine involves treating chronic inflammation by stimulating the vagus nerve using electronic implants. Neurosurgeons have successfully driven serious inflammatory syndromes into remission by sending electric pulses through the nerve. Studies show that electrical stimulation resets the nerve so it produces proresolving compounds, maresins, E-series resolvins, and protectins, in the blood stream instead of inflammatory molecules, like prostaglandins.
Thankfully, we do not all need to jolt one of the body’s primary nerves to keep our proresolving production processes operating smoothly. Weight loss and strenuous exercise also increase SPM production in studies on humans. Government-established dietary and fitness recommendations not only keep our bodies operating in health; they also optimize our recovery systems when we are sick.
The amount of research on SPMs has grown to a critical mass and a database now exists to allow scientists to sort through it all. The Atlas of Inflammation Resolution (AIR) is a recently developed web resource that gathers updated data on various SPMs. The site includes information on the biological processes involved along with details on the molecular pathways and interactions of the modulators. With increased interest in this area prompted by COVID-19, the site is likely to grow at a breakneck pace.
About the Author
Rebecca Guenard is the associate editor of Inform at AOCS. She can be contacted at firstname.lastname@example.org
Specialized pro-resolving mediator network: An update on production and actions, Chiang, N. and C.S. Serhan, Essays Biochem. 3: 443–462, 2020, https://doi.org/10.1042/EBC20200018.
Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology, Sansbury, B.E. and M. Spite, Circ. Res. 119: 113–130, 2016, https://doi.org/10.1161/CIRCRESAHA.116.307308.
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation, Basil, M.C. and B.D. Levy, Nat. Rev. Immunol. 16: 51–67, 2016, https://doi.org/10.1038/nri.2015.4.
Proresolving lipid mediators and mechanisms in the resolution of acute inflammation, Buckley, C.D., D.W. Gilroy, and C.N. Serhan, J. Immuni. 40: 315–327, 2014, https://doi.org/10.1016/j.immuni.2014.02.009.